The University of Arizona
Map Home
Loading...
Adjust height of sidebar
KMap

Topic:sglt2 inhibition

sglt2 inhibition

Since 2021, aggregated from related topics

About

    SGLT2 inhibition is a type of treatment for type 2 diabetes that works by blocking the action of the sodium-glucose cotransporter 2 (SGLT2) protein in the kidneys. This protein is responsible for reabsorbing glucose from the urine back into the bloodstream, so by inhibiting its action, more glucose is excreted in the urine, leading to lower blood sugar levels. SGLT2 inhibitors are a relatively new class of medications and have been shown to be effective in reducing blood sugar levels, as well as offering potential benefits for heart and kidney health.

Related Topics

People

View more people